.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.gif)
.jpg)
Education, Education & Education A Knot in the Sarcoma Awareness and Treatment Outcome
Abstract
Education is the key in the building of society morals, so it help to provide awareness and in the end get the results that society needs. Unfortunately literacy rate of Pakistan is around 60 % that directly tells the story of awareness and the care people getting for their medical problems.
Like other problem in our society Bone and soft tissue sarcomas are also neglected part of our medical side, either because of false beliefs of society, lack of education & awareness, lacking facilities of treating these complicated problems.
References
Sadykova LR, Ntekim AI, Muyangwa-Semenova M, et al. Epidemiology and risk factors of osteosarcoma. Cancer Invest 2020; 38(5): 259-69.
Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 2009; 125(1): 229-34.
Yang C, Tian Y, Zhao F, et al. Bone Microenvironment and osteosarcoma metastasis. Int J Mol Sci 2020; 21(19): 6985.
Biazzo A, De Paolis M. Multidisciplinary approach to osteosarcoma. Acta Orthop Belg 2016; 82(4): 690-8.
Abbasi AN. Establishment and maintenance of quality of site-specific multidisciplinary tumor boards in Pakistan. J Coll Physicians Surg Pak 2016; 26(10): 805-7.
Casali PG, Bielack S, Abecassis N, et al. Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29(Suppl 4): iv79-iv95.
Marina NM, Smeland S, Bielack SS, et al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): An open-label, international, randomised controlled trial. Lancet Oncol 2016; 17(10): 1396-408.
Biermann JS, Chow W, Reed DR, et al. NCCN guidelines insights: bone cancer, version 2. J Natl Compr Canc Netw 2017; 15(2): 155-67.
Yasin NF, Abdul Rashid ML, Ajit Singh V. Survival analysis of osteosarcoma patients: A 15-year experience. J Orthop Surg (Hong Kong) 2020; 28(1): 2309499019896662.
Bajpai J, Puri A, Shah K, et al. Chemotherapy compliance in patients with osteosarcoma. Pediatr Blood Cancer 2013; 60(1): 41-4.
Smeland S, Mu?ller C, Alvegard TA, et al. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003; 39(4): 488-94.
Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20(3): 776-90.
Restrepo DJ, Huayllani MT, Boczar D, et al. Which factors affect survival in patients with upper limb osteosarcoma? Anticancer Res 2019; 39(9): 5027-31.
Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol 2008; 134(3): 281-97.
Xu Z, Mohile SG, Tejani MA, et al. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis. Cancer 2017; 123(1): 52-61.
Kasi A, Abbasi S, Handa S, et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: A systematic review and meta-analysis. JAMA Netw Open 2020; 3(12):e2030097.
Verma P, Jain S, Kapoor G, Tripathi R, Sharma P, Doval DC. IAP chemotherapy regimen is a viable and cost-effective option in children and adolescents with osteosarcoma: A comparative analysis with map regimen on toxicity and survival. J Pediatr Hematol Oncol 2021; 43(4): e466-e71.
Lentz R, Benson AB, 3rd, Kircher S. Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies. J Surg Oncol 2019; 120(1): 85-92.
Rothenberg ML, McCarthy J, Holmes P. Price, cost, and value of cancer medicines: A pharmaceutical industry perspective. Cancer J 2020; 26(4): 281-6.
Evans DR, Lazarides AL, Visgauss JD, et al. Limb salvage versus amputation in patients with osteosarcoma of the extremities: An update in the modern era using the National Cancer Database. BMC Cancer 2020; 20(1): 995.
Longhi A, Errani C, Gonzales-Arabio D, Ferrari C, Mercuri M. Osteosarcoma in patients older than 65 years. J Clin Oncol 2008; 26(33): 5368-73.
Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Transplant 2004; 8(3): 233-
